Novartis ends BioArctic pact; Two VC firms raise inaugural funds

Plus news about Teva, Ultragenyx and Specific Biologics. Novartis cans BioArctic collab: The Swiss pharma axed its discovery-stage work with the Swedish biotech, which created the Alzheimer’s drug Leqembi. The neurodegeneration-focused ...